Paroxysmal supraventricular tachycardia (PSVT) continues to place a significant burden on patients and the health care system. A state-of-the-art review in JACC: Advances examines the evidence supporting current treatment approaches, including vagal maneuvers, medication strategies, and catheter ablation, while highlighting the limitations of traditional acute therapies. It also explores the potential role of recently approved self-administered therapies that may expand treatment options and reduce reliance on emergency care settings.
By continuing to use our site, you agree to our Cookie Policy, Privacy Policy and Terms of Use.
